BINP — Bionoid Pharma Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $5.94m
- $6.05m
Annual balance sheet for Bionoid Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2007 December 31st | 2008 December 31st | 2009 December 31st | 2010 December 31st | 2011 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10KSB | 10-K | 10-K | 10-K | ARS |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.015 | 0.034 | 0.146 | 0.983 | -0 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.042 | 0.039 | 0.151 | 1.03 | 0.017 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.027 | 0.017 | 0.008 | 0.013 | 0.008 |
Net Intangible Assets | |||||
Total Assets | 0.441 | 0.4 | 0.472 | 1.33 | 0.302 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 1.35 | 1.92 | 1.89 | 2.2 | 1.25 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.35 | 1.92 | 1.89 | 2.2 | 1.25 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.914 | -1.52 | -1.42 | -0.871 | -0.948 |
Total Liabilities & Shareholders' Equity | 0.441 | 0.4 | 0.472 | 1.33 | 0.302 |
Total Common Shares Outstanding |